The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 9006798)

Published in Atherosclerosis on November 15, 1996

Authors

R H Böger1, S M Bode-Böger, J C Frölich

Author Affiliations

1: Institute of Clinical Pharmacology, Medical School, Hannover, Germany.

Articles by these authors

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation (1998) 3.25

Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07

Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50

Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation (1997) 2.20

Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res (1988) 1.77

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res (2000) 1.76

Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62

Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin Sci (Lond) (2001) 1.59

Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55

Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure. Eur J Clin Invest (2003) 1.49

Mechanism of antihypertensive action of ketanserin in man. Br Med J (Clin Res Ed) (1983) 1.47

The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol (2001) 1.46

Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther (2000) 1.44

L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol (1998) 1.39

[Aspirin--yes, but 30 mg??]. Z Kardiol (1995) 1.39

Use of ibuprofen and methylprednisolone for the prevention of pain and swelling after removal of impacted third molars. J Oral Maxillofac Surg (1995) 1.36

Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res (1987) 1.35

Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol (1999) 1.32

Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett (2000) 1.29

Pulmonary hypertension correlated to pulmonary thromboxane synthesis. Adv Prostaglandin Thromboxane Res (1980) 1.25

Effect of dexamethasone on in vivo prostanoid production in the rabbit. J Clin Invest (1984) 1.24

Nitric oxide and inflammatory joint diseases. Br J Rheumatol (1998) 1.22

Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. J Biol Chem (1980) 1.21

Extraction and chromatographic procedures for purification of prostaglandins, thromboxanes, prostacyclin, and their metabolites. Adv Prostaglandin Thromboxane Res (1978) 1.19

Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun (1996) 1.19

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler Thromb Vasc Biol (2000) 1.17

L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci (Lond) (1994) 1.14

Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor. J Pharmacol Exp Ther (1986) 1.10

An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol (2000) 1.10

Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells. J Pharmacol Exp Ther (1991) 1.06

Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology (1997) 1.05

Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol (1991) 1.05

L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation (1996) 1.05

Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation (1997) 1.04

The prostaglandin system. A role in canine baroreceptor control of renin release. Circ Res (1978) 1.03

Antidiuretic hormone increases renal prostaglandin synthesis in vivo. Am J Physiol (1978) 1.03

Prevention of postoperative swelling and pain by dexamethasone after operative removal of impacted third molar teeth. Eur J Clin Pharmacol (1993) 1.03

The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med (1978) 1.02

Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis (1995) 1.01

Indomethacin increases plasma lithium. Br Med J (1979) 1.01

N(G)-nitro-L-arginine- and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis (1997) 1.01

Cigarette smoking stimulates cysteinyl leukotriene production in man. Eur J Clin Invest (1997) 1.01

Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol (1994) 1.00

Mechanisms of action of lipoxygenase and cytochrome P-450-mono-oxygenase inhibitors in blocking endothelium-dependent vasodilatation. Br J Pharmacol (1988) 1.00

Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Invest (1996) 1.00

Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Clin Pharmacol Ther (1975) 0.99

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders. J Clin Invest (1993) 0.98

Endothelium-derived relaxing factor influences renal vascular resistance. Am J Physiol (1990) 0.97

Effects of cimetidine and ranitidine on steady-state propranolol kinetics and dynamics. Clin Pharmacol Ther (1982) 0.97

Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl (2000) 0.97

Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol (1998) 0.96

Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Semin Thromb Hemost (2000) 0.96

Plasma levels of sulfinpyrazone and of two of its metabolites after a single dose and during the steady state. Eur J Clin Pharmacol (1983) 0.96

Effects of diclofenac on lithium kinetics. Clin Pharmacol Ther (1981) 0.95

Regional differences in prostacyclin formation by the kidney. Prostacyclin is a major prostaglandin of renal cortex. Biochim Biophys Acta (1978) 0.95

Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids. Kidney Int (1996) 0.94

Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteers. J Cardiovasc Pharmacol (1986) 0.94

Determination of nitric oxide metabolites by means of the Griess assay and gas chromatography-mass spectrometry in the cavernous and systemic blood of healthy males and patients with erectile dysfunction during different functional conditions of the penis. Urol Res (2000) 0.94

Endothelium-dependent relaxation of human epicardial coronary arteries: frequent lack of effect of acetylcholine. Eur J Pharmacol (1986) 0.94

Vascular responses to leukotriene B4, C4 and D4 following FPL 55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat. Br J Pharmacol (1987) 0.93

Effects of acetylsalicylic acid and paracetamol alone and in combination on prostanoid synthesis in man. Br J Clin Pharmacol (1990) 0.92

Importance of NO/EDRF for glomerular and tubular function: studies in the isolated perfused rat kidney. Kidney Int (1992) 0.92

Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ Res (1988) 0.91

Investigations of S-transnitrosylation reactions between low- and high-molecular-weight S-nitroso compounds and their thiols by high-performance liquid chromatography and gas chromatography-mass spectrometry. Anal Biochem (1999) 0.91

Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay--solutions by gas chromatography-mass spectrometry. Anal Biochem (1997) 0.91

The participation of prostaglandins in the control of renin release. Fed Proc (1979) 0.91

Quantification of nitrite and nitrate in human urine and plasma as pentafluorobenzyl derivatives by gas chromatography-mass spectrometry using their 15N-labelled analogs. J Chromatogr B Biomed Appl (1994) 0.91

Indomethacin but not aspirin increases plasma lithium ion levels. Arch Gen Psychiatry (1983) 0.91

[Incidence and prevention of lethal undesirable drug effects]. Internist (Berl) (2003) 0.91

Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention. Circ Res (1979) 0.90

Specific and rapid quantification of 8-iso-prostaglandin F2alpha in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl (1998) 0.90

Artifactual-free analysis of S-nitrosoglutathione and S-nitroglutathione by neutral-pH, anion-pairing, high-performance liquid chromatography. Study on peroxynitrite-mediated S-nitration of glutathione to S-nitroglutathione under physiological conditions. J Chromatogr A (2001) 0.90

Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation. Z Gastroenterol (2002) 0.90

Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. J Am Coll Cardiol (2001) 0.90

Exercise increases systemic nitric oxide production in men. J Cardiovasc Risk (1994) 0.89

Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol (2000) 0.89

Effect of aprotinin on the renal response to vasopressin in diabetes insipidus rats. J Physiol (1983) 0.89

Measurement of prostaglandins, thromboxanes, prostacyclin and their metabolites by gas liquid chromatography--mass spectrometry. Adv Prostaglandin Thromboxane Res (1978) 0.89

Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein binding. Clin Nephrol (2004) 0.88

Analysis of cysteine and N-acetylcysteine in human plasma by high-performance liquid chromatography at the basal state and after oral administration of N-acetylcysteine. J Chromatogr B Biomed Sci Appl (1998) 0.88

Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. Br J Clin Pharmacol (1986) 0.88

Nebivolol decreases systemic oxidative stress in healthy volunteers. Br J Clin Pharmacol (2000) 0.88

Quantitative determination of prostaglandins. Prostaglandins (1973) 0.88

Determination of S-nitrosoglutathione in human and rat plasma by high-performance liquid chromatography with fluorescence and ultraviolet absorbance detection after precolumn derivatization with o-phthalaldehyde. Anal Biochem (1999) 0.87

Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann Rheum Dis (1995) 0.87

Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus. J Pharmacol Exp Ther (1981) 0.87

Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits. Atherosclerosis (1998) 0.87

Alterations in the responses of the sympathetic nervous system and renin in borderline hypertension. Hypertension (1981) 0.86

Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis (1998) 0.86